Cadrenal Therapeutics (CVKD) Current Leases (2022 - 2024)
Cadrenal Therapeutics (CVKD) posted Current Leases of $2232.0 for Q3 2024, down 74.62% sequentially from $8796.0 in Q2 2024, and down 91.07% YoY from $24991.0 in Q4 2023.
Cadrenal Therapeutics (CVKD) Current Leases (2022 - 2024) Analysis & Trends
Cadrenal Therapeutics has reported Current Leases for 3 years, with the latest figure at $2232.0 in Q3 2024.
- Quarterly Current Leases fell 91.07% year-over-year to $2232.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $2232.0 (down 91.07% YoY) and the FY2023 annual result came in at $21350.0, down 4.21% from the prior year.
- Current Leases retreated to $2232.0 in Q3 2024 per CVKD's latest filing, from $8796.0 in the prior quarter.
- Over five years, Current Leases peaked at $24991.0 in Q3 2023 and troughed at $2232.0 in Q3 2024.
- A 3-year average of $17756.1 and a median of $21819.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases fell 4.21% in 2023, then tumbled 91.07% in 2024.
- Over 3 years, Current Leases stood at $22288.0 in 2022, then dropped by 4.21% to $21350.0 in 2023, then sank by 89.55% to $2232.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $2232.0, $8796.0, and $15167.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2,232.00 |
| Jun 30, 2024 | 8,796.00 |
| Mar 31, 2024 | 15,167.00 |
| Dec 31, 2023 | 21,350.00 |
| Sep 30, 2023 | 24,991.00 |
| Jun 30, 2023 | 24,063.00 |
| Mar 31, 2023 | 23,162.00 |
| Dec 31, 2022 | 22,288.00 |